Unknown

Dataset Information

0

Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.


ABSTRACT: Acetyl-CoA carboxylase (ACC) is a key enzyme of fatty acid metabolism with multiple isozymes often expressed in different eukaryotic cellular compartments. ACC-made malonyl-CoA serves as a precursor for fatty acids; it also regulates fatty acid oxidation and feeding behavior in animals. ACC provides an important target for new drugs to treat human diseases. We have developed an inexpensive nonradioactive high-throughput screening system to identify new ACC inhibitors. The screen uses yeast gene-replacement strains depending for growth on cloned human ACC1 and ACC2. In "proof of concept" experiments, growth of such strains was inhibited by compounds known to target human ACCs. The screen is sensitive and robust. Medium-size chemical libraries yielded new specific inhibitors of human ACC2. The target of the best of these inhibitors was confirmed with in vitro enzymatic assays. This compound is a new drug chemotype inhibiting human ACC2 with 2.8 muM IC(50) and having no effect on human ACC1 at 100 muM.

SUBMITTER: Marjanovic J 

PROVIDER: S-EPMC2889071 | biostudies-literature | 2010 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.

Marjanovic Jasmina J   Chalupska Dominika D   Patenode Caroline C   Coster Adam A   Arnold Evan E   Ye Alice A   Anesi George G   Lu Ying Y   Okun Ilya I   Tkachenko Sergey S   Haselkorn Robert R   Gornicki Piotr P  

Proceedings of the National Academy of Sciences of the United States of America 20100503 20


Acetyl-CoA carboxylase (ACC) is a key enzyme of fatty acid metabolism with multiple isozymes often expressed in different eukaryotic cellular compartments. ACC-made malonyl-CoA serves as a precursor for fatty acids; it also regulates fatty acid oxidation and feeding behavior in animals. ACC provides an important target for new drugs to treat human diseases. We have developed an inexpensive nonradioactive high-throughput screening system to identify new ACC inhibitors. The screen uses yeast gene-  ...[more]

Similar Datasets

| S-EPMC4838907 | biostudies-literature
| S-EPMC5226726 | biostudies-literature
| S-EPMC5788913 | biostudies-literature
| S-EPMC4263661 | biostudies-literature
| S-EPMC10777831 | biostudies-literature
| S-EPMC4833862 | biostudies-literature
| S-EPMC3264756 | biostudies-literature
| S-EPMC10594767 | biostudies-literature
| S-EPMC7259786 | biostudies-literature
| S-EPMC2077261 | biostudies-literature